2020
DOI: 10.1021/acssynbio.0c00519
|View full text |Cite
|
Sign up to set email alerts
|

Rational Design of Single Copy Expression Cassettes in Defined Chromosomal Sites Overcomes Intraclonal Cell-to-Cell Expression Heterogeneity and Ensures Robust Antibody Production

Abstract: The expression of endogenous genes as well as transgenes depends on regulatory elements within and surrounding genes as well as their epigenetic modifications. Members of a cloned cell population often show pronounced cell-to-cell heterogeneity with respect to the expression of a certain gene. To investigate the heterogeneity of recombinant protein expression we targeted cassettes into two preselected chromosomal hot-spots in Chinese hamster ovary (CHO) cells. Depending on the gene of interest and the design o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 76 publications
0
3
0
Order By: Relevance
“…This strategy can mitigate integration of fragmented transgene and unpredictable transgene silencing that were observed in recombinant cell lines generated by traditional RI method, and exploit the well‐established and simple RI‐based CLD process. Given that the recombinase‐mediated cassette exchange (RMCE)‐based CLD is increasingly being used for the development of mammalian cell lines that produce therapeutic proteins [ 25 , 26 ], these KI constructs provide relatively high and stable transgene expression sites and streamlined CRISPR/Cas9‐mediated KI without the need for the selection and screening of sgRNA target sequences, suggesting as an alternative to RMCE. These artificial KI constructs can be improved by adjusting the cell‐type independent promoter and customizing the combination of elements.…”
Section: Discussionmentioning
confidence: 99%
“…This strategy can mitigate integration of fragmented transgene and unpredictable transgene silencing that were observed in recombinant cell lines generated by traditional RI method, and exploit the well‐established and simple RI‐based CLD process. Given that the recombinase‐mediated cassette exchange (RMCE)‐based CLD is increasingly being used for the development of mammalian cell lines that produce therapeutic proteins [ 25 , 26 ], these KI constructs provide relatively high and stable transgene expression sites and streamlined CRISPR/Cas9‐mediated KI without the need for the selection and screening of sgRNA target sequences, suggesting as an alternative to RMCE. These artificial KI constructs can be improved by adjusting the cell‐type independent promoter and customizing the combination of elements.…”
Section: Discussionmentioning
confidence: 99%
“…UCOEs have also been tested following site-specific integration into a predetermined genomic site. The Rps3 UCOE and 1.5 kb A2UCOE flanking an antibody light chain transgene stabilised its expression over six weeks of continuous culture at two distinct chromosomal locations [54] . Furthermore, GOI expression was highly homogeneous between individual cells, suggesting that UCOEs allow replicable expression from a single gene copy.…”
Section: Use Of Ucoes In Biomanufacturingmentioning
confidence: 99%
“…The rarity of stable high‐producing cells within these pools necessitated the isolation and screening of hundreds or thousands of clones during a time‐ and resource‐intensive procedure to identify a clonally‐derived cell line with stable and acceptable productivity and product quality attributes, creating a significant bottleneck in the drug development pipeline (Jostock, 2011). Targeted integration platforms, particularly those that employ recombinase‐mediated cassette exchange (RMCE), can accelerate material generation for early product testing by offering unparalleled control over genotype and phenotype (Cain et al, 2013; Carver et al, 2020; Feary et al, 2021; Gödecke et al, 2021; Rajendra et al, 2017; Scarcelli et al, 2017; Shenet al, 2017; Stuible et al, 2018). However, the development of this type of CLD platform first requires knowledge of a precise location within the genome defined as a “hotspot” by its ability to facilitate stable and high transgene expression.…”
Section: Introductionmentioning
confidence: 99%